These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 22136862)
41. Leukaemia cutis presenting as leonine facies. Fadilah SA; Alawiyah AA; Amir MA; Cheong SK Med J Malaysia; 2003 Mar; 58(1):102-4. PubMed ID: 14556333 [TBL] [Abstract][Full Text] [Related]
42. [Primary cutaneous lymphoma--mycosis fungoides]. Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941 [TBL] [Abstract][Full Text] [Related]
43. Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature. del Alcázar-Viladomiu E; Tuneu-Valls A; López-Pestaña A; Vidal-Manceñido MJ Actas Dermosifiliogr; 2015 Sep; 106(7):e33-9. PubMed ID: 25960287 [TBL] [Abstract][Full Text] [Related]
44. Exceptionally long disease-free period in a case of Sézary syndrome after combined treatment with leukapheresis and chemotherapy. Di Guglielmo R; Miliani A; Avanzi G; Cozzolino F; Duminuco M; Vannucci R; Occhini U Haematologica; 1987; 72(6):541-3. PubMed ID: 3126113 [No Abstract] [Full Text] [Related]
45. [A case of effective use of alemtuzumab in a male patient with T-cell lymphoma]. Sokolov AH; Parovichnikova EN; Isaev VG; Ustinova EN; Shavlokhov VS; Atopkov VA; Model SV; Tsyba NN; Kaplanskaia IB; Kliasova GA; Aleksanian MZh; Vishnevskaia ES; Togonidze DK; Mirzoian EE; Savchenko VG Ter Arkh; 2004; 76(12):73-5. PubMed ID: 15724932 [No Abstract] [Full Text] [Related]
47. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK; Mullins FM; Kim YH; Kong CS Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone. Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945 [No Abstract] [Full Text] [Related]
55. Mycosis fungoides and the Sézary syndrome. Kim YH; Hoppe RT Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085 [TBL] [Abstract][Full Text] [Related]
56. Neurolymphomatosis associated with Sézary syndrome. Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760 [TBL] [Abstract][Full Text] [Related]
57. A case of bullous Sézary syndrome. Ono A; Isomura I; Isogai Z; Shintani Y; Suzuki A; Morita A J Dermatol; 2004 Dec; 31(12):1027-31. PubMed ID: 15801270 [TBL] [Abstract][Full Text] [Related]
58. A typical case of Sezary syndrome mimicking an eczema. Akouaouach H; Mortaki A; Pepersack T Acta Clin Belg; 2005; 60(1):13-6. PubMed ID: 15981699 [TBL] [Abstract][Full Text] [Related]
59. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies. Foss FM Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054 [TBL] [Abstract][Full Text] [Related]
60. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature. Li Y; Li Z; Lin HL; Chen XH; Li B Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]